| 摘要 |
FIELD: medicine.SUBSTANCE: group of inventions refers to medicine and concerns a method for diagnosing and monitoring disturbed activity and/or function of the gastrointestinal tract, except for somatostatinoma, in the patients, wherein the method involves the stages of sampling physiological fluid in the patient, measuring prosomatostatin 1-64 or its fragments in the above sample, correlating prosomatostatin 1-64 or its fragments to the diagnosis of disturbed activity and/or function of the gastrointestinal tract, except for somatostatinoma, determined in the above patient. The group of inventions also concerns a kit for measuring prosomatostatin 1-64 or its fragments comprising at least two antibodies. The group of invention provides diagnosing and monitoring disturbed activity and/or function of the gastrointestinal tract specified in a group consisting of Crohn's disease, pancreatitis, diverticulitis, pancreatic carcinoma, pancreatic neocarcinoma, oesophageal carcinoma, gastric carcinoma, colonic carcinoma or colonic neocarcinoma.EFFECT: improving the method for diagnosing and monitoring disturbed activity and/or function of the gastrointestinal tract.10 cl, 9 dwg, 1 tbl, 1 ex |
